These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28321052)

  • 1. Saline Infusion Test highly associated with the incidence of cardio- and cerebrovascular events in primary aldosteronism.
    Hayashi R; Tamada D; Murata M; Mukai K; Kitamura T; Otsuki M; Shimomura I
    Endocr J; 2017 May; 64(5):507-513. PubMed ID: 28321052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The number of positive confirmatory tests is associated with the clinical presentation and incidence of cardiovascular and cerebrovascular events in primary aldosteronism.
    Saiki A; Tamada D; Hayashi R; Mukai K; Kitamura T; Takahara M; Otsuki M; Shimomura I
    Hypertens Res; 2019 Aug; 42(8):1186-1191. PubMed ID: 30850754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmatory testing in primary aldosteronism.
    Nanba K; Tamanaha T; Nakao K; Kawashima ST; Usui T; Tagami T; Okuno H; Shimatsu A; Suzuki T; Naruse M
    J Clin Endocrinol Metab; 2012 May; 97(5):1688-94. PubMed ID: 22419718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism.
    Lin C; Yang J; Fuller PJ; Jing H; Song Y; He W; Du Z; Luo T; Cheng Q; Yang S; Wang H; Li Q; Hu J;
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):131-137. PubMed ID: 31774187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parameters of captopril challenge test can predict results of other confirmatory tests for primary aldosteronism and propose the next test to be done.
    Tamura N; Yamada K; Hatakeyama H; Torii-Hanakita M; Kyo C; Kosugi R; Yonemoto T; Ogawa T; Kotani M; Usui T; Inoue T
    Endocr J; 2020 Jul; 67(7):741-750. PubMed ID: 32249243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACTH stimulation test and computed tomography are useful for differentiating the subtype of primary aldosteronism.
    Moriya A; Yamamoto M; Kobayashi S; Nagamine T; Takeichi-Hattori N; Nagao M; Harada T; Tanimura-Inagaki K; Onozawa S; Murata S; Tamura H; Fukuda I; Oikawa S; Sugihara H
    Endocr J; 2017 Jan; 64(1):65-73. PubMed ID: 27725373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes Mellitus Itself Increases Cardio-Cerebrovascular Risk and Renal Complications in Primary Aldosteronism.
    Saiki A; Otsuki M; Tamada D; Kitamura T; Shimomura I; Kurihara I; Ichijo T; Takeda Y; Katabami T; Tsuiki M; Wada N; Yanase T; Ogawa Y; Kawashima J; Sone M; Inagaki N; Yoshimoto T; Okamoto R; Takahashi K; Kobayashi H; Tamura K; Kamemura K; Yamamoto K; Izawa S; Kakutani M; Yamada M; Tanabe A; Naruse M
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32275055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of Discordant Results Between Confirmatory Tests in Diagnosis of Primary Aldosteronism.
    Fukumoto T; Umakoshi H; Ogata M; Yokomoto-Umakoshi M; Matsuda Y; Motoya M; Nagata H; Nakano Y; Iwahashi N; Kaneko H; Wada N; Miyazawa T; Sakamoto R; Ogawa Y
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e866-e874. PubMed ID: 33165595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Saline Infusion Test and the Captopril Challenge Test in Chinese Patients With Primary Aldosteronism.
    Meng X; Li Y; Wang X; Li J; Liu Y; Yu Y
    J Clin Endocrinol Metab; 2018 Mar; 103(3):853-860. PubMed ID: 29300995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism.
    Mulatero P; Monticone S; Bertello C; Viola A; Tizzani D; Iannaccone A; Crudo V; Burrello J; Milan A; Rabbia F; Veglio F
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4826-33. PubMed ID: 24057288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline Plasma Aldosterone Level and Renin Activity Allowing Omission of Confirmatory Testing in Primary Aldosteronism.
    Kawashima J; Araki E; Naruse M; Kurihara I; Takahashi K; Tamura K; Kobayashi H; Okamura S; Miyauchi S; Yamamoto K; Izawa S; Suzuki T; Tanabe A
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32157288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of aging on the diagnosis of primary aldosteronism.
    Nakama C; Kamide K; Kawai T; Hongyo K; Ito N; Onishi M; Takeya Y; Yamamoto K; Sugimoto K; Rakugi H
    Hypertens Res; 2014 Dec; 37(12):1062-7. PubMed ID: 25164207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmatory Tests for the Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study.
    Song Y; Yang S; He W; Hu J; Cheng Q; Wang Y; Luo T; Ma L; Zhen Q; Zhang S; Mei M; Wang Z; Qing H; Bruemmer D; Peng B; Li Q;
    Hypertension; 2018 Jan; 71(1):118-124. PubMed ID: 29158354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do multiple types of confirmatory tests improve performance in predicting subtypes of primary aldosteronism?
    Kaneko H; Umakoshi H; Fukumoto T; Wada N; Ichijo T; Sakamoto S; Watanabe T; Ishihara Y; Tagami T; Ogata M; Iwahashi N; Yokomoto-Umakoshi M; Matsuda Y; Sakamoto R; Ogawa Y
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):473-480. PubMed ID: 36415024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
    Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
    J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusion Tests in Unilateral Primary Aldosteronism (ExcluPA) Study.
    Zhu R; Shagjaa T; Rossitto G; Caroccia B; Seccia TM; Gregori D; Rossi GP
    J Clin Endocrinol Metab; 2023 Jan; 108(2):496-506. PubMed ID: 36373399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seated Saline Suppression Test Is Comparable With Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study.
    Liu B; Hu J; Song Y; He W; Cheng Q; Wang Z; Feng Z; Du Z; Xu Z; Yang J; Li Q; Yang S;
    Endocr Pract; 2021 Apr; 27(4):326-333. PubMed ID: 33779561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism.
    Weigel M; Riester A; Hanslik G; Lang K; Willenberg HS; Endres S; Allolio B; Beuschlein F; Reincke M; Quinkler M
    Eur J Endocrinol; 2015 Apr; 172(4):443-50. PubMed ID: 25630564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry.
    Born-Frontsberg E; Reincke M; Rump LC; Hahner S; Diederich S; Lorenz R; Allolio B; Seufert J; Schirpenbach C; Beuschlein F; Bidlingmaier M; Endres S; Quinkler M;
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1125-30. PubMed ID: 19190103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 3: Confirmatory testing.
    Reznik Y; Amar L; Tabarin A
    Ann Endocrinol (Paris); 2016 Jul; 77(3):202-7. PubMed ID: 27318644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.